We are live on ! Find out more
RPRX

Repros Therapeutics Inc.
RPRX

Delisted

RPRX was delisted on the 31st of January, 2018.

Back to rankings

72 hedge funds and large institutions have $135M invested in Repros Therapeutics Inc. in 2015 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 30 increasing their positions, 16 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

131% more call options, than puts

Call options by funds: $9.51M | Put options by funds: $4.11M

88% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 16

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

10% less funds holding

Funds holding: 80 → 72 (-8)

16% less capital invested

Capital invested by funds: $160M → $135M (-$24.9M)

53% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 15

Holders
72
Holders Change
-8
Holders Change %
-10%
% of All Funds
1.92%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
7
Increased
30
Reduced
16
Closed
15
Calls
$9.51M
Puts
$4.11M
Net Calls
+$5.4M
Net Calls Change
+$3.82M

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$2.57M
2
HCMT
Highland Capital Management (Texas)
Texas
+$2.09M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$1.02M
4
Deutsche Bank
Deutsche Bank
Germany
+$600K
5
CWG
C WorldWide Group
Denmark
+$581K

Top Sellers

Rank Fund Capital Flow
1
SAM
Senzar Asset Management
New York
-$4.65M
2
SM
Sabby Management
Florida
-$2.5M
3
ST
Spot Trading
Illinois
-$1.03M
4
SFM
Sphera Funds Management
Israel
-$997K
5
Goldman Sachs
Goldman Sachs
New York
-$952K
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$27M +$1.02M +114,090 +4%
BBA
2
Baker Bros. Advisors
New York
$17.2M – – –
SCM
3
Sarissa Capital Management
Connecticut
$9.73M – – –
BIT
4
BlackRock Institutional Trust
California
$7.32M +$14K +1,561 +0.2%
Vanguard Group
5
Vanguard Group
Pennsylvania
$6.07M +$507K +56,682 +9%
CC
6
CQS Cayman
Cayman Islands
$6.01M – – –
BFA
7
BlackRock Fund Advisors
California
$5.95M +$230K +25,700 +4%
Millennium Management
8
Millennium Management
New York
$5.76M +$2.57M +287,553 +75%
GAI
9
General American Investors
New York
$4.37M – – –
Bank of America
10
Bank of America
North Carolina
$3.15M +$209K +23,372 +7%
State Street
11
State Street
Massachusetts
$3.11M +$23.1K +2,581 +0.7%
DCM
12
Destrier Capital Management
New York
$2.83M – – –
HCMT
13
Highland Capital Management (Texas)
Texas
$2.81M +$2.09M +233,277 +248%
GCM
14
Gruss Capital Management
New York
$2.61M +$250K +28,000 +10%
Northern Trust
15
Northern Trust
Illinois
$2.53M +$6.8K +760 +0.3%
SAM
16
Senzar Asset Management
New York
$2.1M -$4.65M -520,400 -68%
RI
17
RTW Investments
New York
$1.97M – – –
Morgan Stanley
18
Morgan Stanley
New York
$1.86M +$254K +28,421 +15%
FCM
19
Farallon Capital Management
California
$1.72M -$894K -100,000 -33%
CWG
20
C WorldWide Group
Denmark
$1.72M +$581K +65,000 +48%
RA
21
Royce & Associates
New York
$1.64M -$537K -60,000 -24%
Fuller & Thaler Asset Management
22
Fuller & Thaler Asset Management
California
$1.42M – – –
Bank of New York Mellon
23
Bank of New York Mellon
New York
$1.25M +$103K +11,553 +9%
JGC
24
J. Goldman & Co
New York
$1.2M +$125K +14,000 +11%
TCIM
25
TIAA CREF Investment Management
New York
$1.19M +$106K +11,842 +9%
1
2 3 4

RPRX Hedge Fund Activity: Q1 2015 in Review

72 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Repros Therapeutics Inc. (RPRX) for Q1 2015, worth a combined $135M — down 16% from $160M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of RPRX and 7 opened new positions — a net loss of 8 holders — while 16 trimmed existing stakes and 30 added.

The largest buyer was Millennium Management, adding an estimated $2.57M. The largest seller was Senzar Asset Management, cutting an estimated $4.65M.

  • 72 institutional investors held Repros Therapeutics Inc. (RPRX) as of Q1 2015, down from 80 in Q4 2014.
  • Funds reported $135M of Repros Therapeutics Inc. stock for Q1 2015, down 16% quarter-over-quarter.
  • 7 funds opened new Repros Therapeutics Inc. positions in Q1 2015 and 15 closed out, a net change of -8 holders.
  • The largest Repros Therapeutics Inc. buyer in Q1 2015 was Millennium Management, an estimated $2.57M added.
  • The largest Repros Therapeutics Inc. seller in Q1 2015 was Senzar Asset Management, an estimated $4.65M sold.

Based on aggregated 13F filings for Q1 2015.